Patient Guide: A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07033494
Status: 🟢 Enrolling Now
Condition: Early Alzheimer's Disease
Phase: PHASE2

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Inglewood, California
  • • Irvine, California
  • • Long Beach, California
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) - Join Clinical Trial NCTNCT07033494

How to Join This Clinical Trial - NCTNCT07033494

Learn how to participate in this PHASE2 trial studying an investigational therapy for Early Alzheimer's Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Early Alzheimer's Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Early Alzheimer's Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07033494 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Inglewood, California 90301 - United States

Status: RECRUITING

Clinical Research Site

Irvine, California 92614 - United States

Status: RECRUITING

Clinical Research Site

Long Beach, California 90804 - United States

Status: RECRUITING

Clinical Research Site

Redlands, California 92374 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94158 - United States

Status: RECRUITING

Clinical Research Site

Santa Ana, California 92705 - United States

Status: RECRUITING

Clinical Research Site

Atlantis, Florida 33462 - United States

Status: RECRUITING

Clinical Research Site

Fort Myers, Florida 33912 - United States

Status: RECRUITING

Clinical Research Site

Maitland, Florida 32750 - United States

Status: RECRUITING

Clinical Research Site

Melbourne, Florida 32940 - United States

Status: RECRUITING

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Early Alzheimer's Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships